The real-time monitoring of intravascular oxygen levels is important to accurately track the cardiopulmonary health of patients after cardiothoracic surgery. Existing methods use intravascular placement of glass fiber-optic ...
Heart failure is a major public health concern, a disease that affects tens of millions of people around the world—forcing many into a vicious cycle of hospitalizations, discharges and frequent readmissions.
The Lipid Hypothesis of coronary artery disease has long held that a high level of cholesterol is the causative factor of atherosclerosis, but a group of New York scientists is making a powerful case for platelets as the ...
The long-sought Holy Grail for heart attack patients has been a method to regenerate healthy new tissue, but the basic building blocks required to remodel an injured heart have remained elusive—until now.
Cells switch fates and acquire new identities during organogenesis and regeneration as a critical trait, although the mechanisms underlying such conversions are poorly understood. The vasculature provides a biological model ...
Coronary artery disease (CAD) is the most common cause of illness-based death throughout the world. According to the World Health Organization, CAD causes 17.9 million deaths per year worldwide, nearly one-third of all illness-based ...
Cleveland Clinic researchers have identified a new pathway that contributes to cardiovascular disease associated with high levels of niacin, a common B vitamin previously recommended to lower cholesterol.
Feb 19, 2024
2
146
A multi-institution research effort led by Harvard Medical School, Boston, has looked into the safety and efficacy of excluding aspirin from the treatment of patients with advanced heart failure receiving a fully magnetically ...
Cardiac pacemakers are battery-dependent, where the pacing leads are prone to introduce valve damage and infection. In addition, complete pacemaker retrieval is necessary for battery replacement. Despite the presence of a ...
A multi-institution study led by the Prince of Wales Hospital and University of New South Wales, Australia, has found that everolimus-eluting resorbable scaffold treatment leads to better outcomes than angioplasty for chronic ...
